Colonial Trust
HRMY icon

Colonial Trust’s Harmony Biosciences HRMY Stock Holding History

Colonial Trust’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.86K Buy
+73
New +$2.82K ﹤0.01% 957

Other funds holding HRMY

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $229B AUM 33.35% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $54.1B AUM 39.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return

Colonial Trust's HRMY Position: Q3 2026 in Review

Colonial Trust opened a new position in Harmony Biosciences (HRMY) in Q3 2026: 73 shares worth $2.86K. The stake represents ﹤0.01% of the portfolio and ranks #957 among its holdings.

279 funds tracked by Wall St. Rank hold HRMY as of Q3 2026.

  • Colonial Trust held 73 shares of Harmony Biosciences worth $2.86K as of Q3 2026.
  • Harmony Biosciences was a new Colonial Trust position in Q3 2026.
  • Harmony Biosciences made up ﹤0.01% of Colonial Trust's portfolio in Q3 2026, its #957 holding.
  • 279 funds tracked by Wall St. Rank held Harmony Biosciences as of Q3 2026.

Based on Colonial Trust's 13F filing for Q3 2026, filed 10 Nov 2026.